Epstein Becker Green Closes Venture Capital Investment
On August 13, 2010, Epstein Becker Green closed an investment by its client Radius Ventures in a company called HealthSense, Inc. (http://www.healthsense.com). HealthSense provides technology solutions for the future of aging services. The deal involved a venture capital investment of $4 million.
Radius Ventures was represented by Epstein Becker Green attorneys Robert D. Reif, in the Washington, DC, office; Purvi Badiani Maniar and Hylan B. Fenster, in the New York office; and Lisa J. Matyas, in the Chicago office.
Epstein Becker Green Closes $46.5 Million Sale of Genetics Laboratory Client
On August 7, 2015, Epstein Becker Green attorneys, acting as deal counsel to the principals of Reprogenetics, LLC, successfully closed the sale of Reprogenetics’ equity to CooperSurgical, Inc., for approximately $46.5 million. Reprogenetics, headquartered in Livingston, New Jersey, is the largest genetics laboratory specializing in preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the in-vitro fertilization (IVF) process. CooperSurgical is one of two business units of The Cooper Companies, Inc., a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). This transaction will enable CooperSurgical to strengthen its IVF business.
The Epstein Becker Green team included Purvi B. Maniar, Stephanie G. Lerman, Arthur J. Fried, Steven A. Ruskin, and Benjamin M. Zegarelli.